Open AccessPharmacogenetic Testing in Primary Care Practice: Opinions of Physicians, Pharmacists and Patients
Author(s) -
Marie-Pier Frigon,
Marie-Ève Blackburn,
Camélia Dubois-Bouchard,
Ann-Lorie Gag,
Suzie Tardif,
Karine Tremblay
Publication year - 2019
Publication title -
pharmacogenomics
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.541
H-Index - 91
eISSN - 1744-8042
pISSN - 1462-2416
DOI - 10.2217/pgs-2019-0004
Subject(s) - pharmacogenetics , enthusiasm , family medicine , focus group , medicine , set (abstract data type) , primary care , health care , medical education , psychology , political science , business , computer science , biochemistry , chemistry , genotype , gene , social psychology , marketing , law , programming language
Aim: Although health authorities have set pharmacogenetic (PGx) markers on labels of hundreds of drugs, the use of PGx in clinical care remains infrequent. The adoption of PGx will depend on the opinions of physicians, pharmacists and patients. Materials & methods: Qualitative focus group interviews were performed with 23 physicians, 11 pharmacists and 30 patients. Results: Majority of the participants showed enthusiasm toward the implementation of PGx in clinics. Lack of knowledge on PGx, roles of healthcare providers, factors in favor and challenges of PGx implementation, ethical and insurance issues, educational and tools needs were the key themes that emerged from the interviews. Conclusion: Several barriers impede the uptake of PGx in clinics, however, opinions of physicians, pharmacists and patients are mostly favorable.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom